Hamid Rabb

Hamid Rabb

Auto-generated profile, based on publicly available information

Hamid Rabb

Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD 21205

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
HRHamid Rabb
Hamid Rabb
Matthew GriffinMatthew Griffin
Matthew Griffin
DMDianne B. McKay
Dianne B. McKay
SSSundararaman Swaminathan
Sundararaman Swaminathan
PPPeter Pickkers
Peter Pickkers
CRClaudio Ronco
Claudio Ronco
Inflammation is a complex biologic response that is essential for eliminating microbial pathogens and repairing tissue after injury. AKI associates with intrarenal and systemic inflammation; thus, improved understanding of the cellular and molecular mechanisms underlying the inflammatory response has high potential for identifying effective therapies to prevent or ameliorate AKI. In the past decade, much knowledge has been generated about the fundamental mechanisms of inflammation. Experimental work in small animal models has revealed many details of the inflammatory response that occurs within the kidney after typical causes of AKI, including insights into the molecular signals released by dying cells, the role of pattern recognition receptors, the diverse subtypes of resident and recruited immune cells, and the phased transition from destructive to reparative inflammation. Although this expansion of the basic knowledge base has increased the number of mechanistically relevant targets of intervention, progress in developing therapies that improve AKI outcomes by modulation of inflammation remains slow. In this article, we summarize the most important recent developments in understanding the inflammatory mechanisms of AKI, highlight key limitations of the commonly used animal models and clinical trial designs that may prevent successful clinical application, and suggest priority approaches for research toward clinical translation in this area.

1 January 2009 in Clinical Immunology
Verified
Journal Article
Closed access
HJHye Ryoun Jang
Hye Ryoun Jang
HRHamid Rabb
Hamid Rabb

1 December 2018 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
SLSul A Lee
Sul A Lee
MCMartina Cozzi
Martina Cozzi
EBErrol L. Bush
Errol L. Bush
HRHamid Rabb
Hamid Rabb

1 August 2009 in Kidney International
Verified
Journal Article
Closed access
MLManchang Liu
Manchang Liu
DGDmitry N. Grigoryev
Dmitry N. Grigoryev
MCMichael T. Crow
Michael T. Crow
MHMark Haas
Mark Haas
MYMasayuki Yamamoto
Masayuki Yamamoto
HRHamid Rabb
Hamid Rabb

1 May 2012 in Kidney International
Verified
Journal Article
Closed access
MGMorgan E. Grams
Morgan E. Grams
HRHamid Rabb
Hamid Rabb

1 January 2009 in Transplantation Reviews
Verified
Journal Article
Closed access
DLDouglas Linfert
Douglas Linfert
TCTayseer Chowdhry
Tayseer Chowdhry
HRHamid Rabb
Hamid Rabb